SEC Form D private-offering filing

Antigenix Therapeutics, Inc.

Name: Antigenix Therapeutics, Inc. - new SEC Form D private-offering filing, Princeton, NJ
Published: 2025-10-24

A new SEC Form D private-offering notice from Princeton, NJ, a $8,363,695 filer-stated offering target in Biotech. The source filing is one click away.

Antigenix Therapeutics, Inc. site↗ Verified via SEC Form D

Develops precision antibody drug conjugate therapies designed to target cancer cells such as triple negative breast, ovarian, prostate and colon cancers.

Filed 2025-10-24Filed to raise $8,363,695First money in 2025-10-22Raised so far $3,363,695HQ (as filed) Princeton, NJSector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified antigenixthera.com↗Named in the filing 3 executives & directors

Open this row on the live feed →More new filings in New Jersey →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.